Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder
Authors
Keywords
Cocaine use disorder, Substance-related disorders, Addictive behaviors, GLP-1, Exenatide, Cocaine self-administration
Journal
DRUG AND ALCOHOL DEPENDENCE
Volume 221, Issue -, Pages 108614
Publisher
Elsevier BV
Online
2021-02-16
DOI
10.1016/j.drugalcdep.2021.108614
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Central GLP-1 receptors: Novel molecular targets for cocaine use disorder
- (2019) N.S. Hernandez et al. PHYSIOLOGY & BEHAVIOR
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Exenatide once weekly for smoking cessation
- (2018) Luba Yammine et al. MEDICINE
- Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats
- (2018) Nicole S. Hernandez et al. NEUROPSYCHOPHARMACOLOGY
- Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial
- (2018) Kerstin K Antonsen et al. BMJ Open
- Cocaine and cocaine expectancy increase growth hormone, ghrelin, GLP-1, IGF-1, adiponectin, and corticosterone while decreasing leptin, insulin, GIP, and prolactin
- (2018) Zhi-Bing You et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists
- (2015) Sten Madsbad DIABETES OBESITY & METABOLISM
- Peripheral Mechanisms in Appetite Regulation
- (2015) Michael Camilleri GASTROENTEROLOGY
- Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine
- (2015) Heath D Schmidt et al. NEUROPSYCHOPHARMACOLOGY
- Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior
- (2015) Anne E Harasta et al. NEUROPSYCHOPHARMACOLOGY
- The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice
- (2015) Gunnar Sørensen et al. PHYSIOLOGY & BEHAVIOR
- Incretins and Amylin: Neuroendocrine Communication Between the Gut, Pancreas, and Brain in Control of Food Intake and Blood Glucose
- (2014) Matthew R. Hayes et al. Annual Review of Nutrition
- GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans
- (2014) L. van Bloemendaal et al. DIABETES
- Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight
- (2014) Laurie L. Baggio et al. JOURNAL OF CLINICAL INVESTIGATION
- The skinny on cocaine: Insights into eating behavior and body weight in cocaine-dependent men
- (2013) Karen D. Ersche et al. APPETITE
- The Addictive Dimensionality of Obesity
- (2013) Nora D. Volkow et al. BIOLOGICAL PSYCHIATRY
- The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice
- (2013) Emil Egecioglu et al. PLoS One
- The Effect of Glucagon-Like Peptide-1 Receptor Agonist Therapy on Body Mass Index in Adolescents With Severe Obesity
- (2013) Aaron S. Kelly et al. JAMA Pediatrics
- Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers
- (2012) Rebecca L Ashare et al. JOURNAL OF PSYCHOPHARMACOLOGY
- GLP-1 analog attenuates cocaine reward
- (2012) D L Graham et al. MOLECULAR PSYCHIATRY
- A single-day paradigm of self-regulated human cocaine administration
- (2012) D. Matuskey et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Exendin-4 decreases amphetamine-induced locomotor activity
- (2012) Kevin Erreger et al. PHYSIOLOGY & BEHAVIOR
- Novel pharmacotherapeutic treatments for cocaine addiction
- (2011) Daryl Shorter et al. BMC Medicine
- Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes
- (2011) J. Dushay et al. DIABETES CARE
- The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide
- (2011) Scott E. Kanoski et al. NEUROPHARMACOLOGY
- Efficacy of Varenicline to Prompt Quit Attempts in Smokers Not Currently Trying to Quit: A Randomized Placebo-Controlled Trial
- (2011) J. R. Hughes et al. NICOTINE & TOBACCO RESEARCH
- The role of gut hormones and the hypothalamus in appetite regulation
- (2010) Keisuke Suzuki et al. ENDOCRINE JOURNAL
- Exenatide: A new promising antidiabetic agent
- (2010) CK Chakraborti INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Regulation of cocaine self-administration in humans: Lack of evidence for loading and maintenance phases
- (2009) Gustavo A. Angarita et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cocaine decreases plasma insulin concentrations in non-diabetic subjects: a randomized double-blind study
- (2008) D. Rott et al. DIABETIC MEDICINE
- Common predictors of smoking cessation in clinical practice
- (2008) Pasquale Caponnetto et al. RESPIRATORY MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More